nodes	percent_of_prediction	percent_of_DWPC	metapath
Diphenhydramine—Tamoxifen—pancreatic cancer	0.501	1	CrCtD
Diphenhydramine—Bedaquiline—Tamoxifen—pancreatic cancer	0.0462	0.133	CrCrCtD
Diphenhydramine—Clomifene—Tamoxifen—pancreatic cancer	0.042	0.121	CrCrCtD
Diphenhydramine—Toremifene—Tamoxifen—pancreatic cancer	0.0279	0.0805	CrCrCtD
Diphenhydramine—Naftifine—Tamoxifen—pancreatic cancer	0.0231	0.0666	CrCrCtD
Diphenhydramine—Levomethadyl Acetate—Tamoxifen—pancreatic cancer	0.0186	0.0535	CrCrCtD
Diphenhydramine—Methadyl Acetate—Tamoxifen—pancreatic cancer	0.0186	0.0535	CrCrCtD
Diphenhydramine—CYP2B6—Tamoxifen—pancreatic cancer	0.0179	0.141	CbGbCtD
Diphenhydramine—Cyclobenzaprine—Tamoxifen—pancreatic cancer	0.0174	0.0503	CrCrCtD
Diphenhydramine—Doxylamine—Tamoxifen—pancreatic cancer	0.016	0.0462	CrCrCtD
Diphenhydramine—Dextropropoxyphene—Tamoxifen—pancreatic cancer	0.0152	0.0439	CrCrCtD
Diphenhydramine—Phenoxybenzamine—Tamoxifen—pancreatic cancer	0.0152	0.0439	CrCrCtD
Diphenhydramine—Tripelennamine—Tamoxifen—pancreatic cancer	0.0145	0.0418	CrCrCtD
Diphenhydramine—CYP2B6—Irinotecan—pancreatic cancer	0.0137	0.108	CbGbCtD
Diphenhydramine—Bromodiphenhydramine—Tamoxifen—pancreatic cancer	0.0136	0.0391	CrCrCtD
Diphenhydramine—Dimetacrine—Tamoxifen—pancreatic cancer	0.0136	0.0391	CrCrCtD
Diphenhydramine—CYP1A2—Dacarbazine—pancreatic cancer	0.0132	0.104	CbGbCtD
Diphenhydramine—Methadone—Tamoxifen—pancreatic cancer	0.0127	0.0367	CrCrCtD
Diphenhydramine—CYP2C19—Tamoxifen—pancreatic cancer	0.0114	0.0896	CbGbCtD
Diphenhydramine—Clofedanol—Tamoxifen—pancreatic cancer	0.011	0.0317	CrCrCtD
Diphenhydramine—Orphenadrine—Tamoxifen—pancreatic cancer	0.0107	0.0307	CrCrCtD
Diphenhydramine—Benzphetamine—Tamoxifen—pancreatic cancer	0.0107	0.0307	CrCrCtD
Diphenhydramine—CYP1A2—Tamoxifen—pancreatic cancer	0.0105	0.0827	CbGbCtD
Diphenhydramine—Promazine—Tamoxifen—pancreatic cancer	0.0102	0.0293	CrCrCtD
Diphenhydramine—Benzyl Benzoate—Tamoxifen—pancreatic cancer	0.00987	0.0285	CrCrCtD
Diphenhydramine—CYP2C9—Tamoxifen—pancreatic cancer	0.00944	0.0745	CbGbCtD
Diphenhydramine—CYP1A2—Erlotinib—pancreatic cancer	0.00891	0.0703	CbGbCtD
Diphenhydramine—CYP2D6—Tamoxifen—pancreatic cancer	0.00863	0.0681	CbGbCtD
Diphenhydramine—CYP1A2—Fluorouracil—pancreatic cancer	0.00772	0.0609	CbGbCtD
Diphenhydramine—CYP2B6—Doxorubicin—pancreatic cancer	0.0075	0.0592	CbGbCtD
Diphenhydramine—CYP2D6—Erlotinib—pancreatic cancer	0.00734	0.0579	CbGbCtD
Diphenhydramine—CYP2C9—Fluorouracil—pancreatic cancer	0.00696	0.0549	CbGbCtD
Diphenhydramine—CYP2D6—Doxorubicin—pancreatic cancer	0.00362	0.0286	CbGbCtD
Diphenhydramine—Chest tightness—Docetaxel—pancreatic cancer	0.000473	0.0199	CcSEcCtD
Diphenhydramine—Neuritis—Gemcitabine—pancreatic cancer	0.000419	0.0176	CcSEcCtD
Diphenhydramine—Haemolytic anaemia—Erlotinib—pancreatic cancer	0.000362	0.0152	CcSEcCtD
Diphenhydramine—Nasal congestion—Sunitinib—pancreatic cancer	0.00031	0.0131	CcSEcCtD
Diphenhydramine—Neuritis—Docetaxel—pancreatic cancer	0.000297	0.0125	CcSEcCtD
Diphenhydramine—Euphoric mood—Fluorouracil—pancreatic cancer	0.000264	0.0111	CcSEcCtD
Diphenhydramine—Photosensitivity—Fluorouracil—pancreatic cancer	0.000254	0.0107	CcSEcCtD
Diphenhydramine—Chest discomfort—Docetaxel—pancreatic cancer	0.000251	0.0105	CcSEcCtD
Diphenhydramine—Neuropathy peripheral—Erlotinib—pancreatic cancer	0.000247	0.0104	CcSEcCtD
Diphenhydramine—Neuropathy peripheral—Sunitinib—pancreatic cancer	0.000214	0.00898	CcSEcCtD
Diphenhydramine—Irritability—Fluorouracil—pancreatic cancer	0.000213	0.00895	CcSEcCtD
Diphenhydramine—Chills—Erlotinib—pancreatic cancer	0.000203	0.00853	CcSEcCtD
Diphenhydramine—Neuritis—Epirubicin—pancreatic cancer	0.0002	0.00843	CcSEcCtD
Diphenhydramine—Sweating increased—Irinotecan—pancreatic cancer	0.000196	0.00825	CcSEcCtD
Diphenhydramine—Neuritis—Doxorubicin—pancreatic cancer	0.000185	0.0078	CcSEcCtD
Diphenhydramine—Photosensitivity reaction—Fluorouracil—pancreatic cancer	0.000176	0.0074	CcSEcCtD
Diphenhydramine—Chills—Sunitinib—pancreatic cancer	0.000175	0.00738	CcSEcCtD
Diphenhydramine—Neuropathy peripheral—Gemcitabine—pancreatic cancer	0.000171	0.00721	CcSEcCtD
Diphenhydramine—Neuropathy peripheral—Fluorouracil—pancreatic cancer	0.000168	0.00709	CcSEcCtD
Diphenhydramine—Dry mouth—Tamoxifen—pancreatic cancer	0.000165	0.00696	CcSEcCtD
Diphenhydramine—Agranulocytosis—Gemcitabine—pancreatic cancer	0.000163	0.00686	CcSEcCtD
Diphenhydramine—Agranulocytosis—Fluorouracil—pancreatic cancer	0.00016	0.00675	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Tamoxifen—pancreatic cancer	0.000159	0.00668	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Erlotinib—pancreatic cancer	0.000157	0.00661	CcSEcCtD
Diphenhydramine—Hyperhidrosis—Tamoxifen—pancreatic cancer	0.000157	0.0066	CcSEcCtD
Diphenhydramine—Anorexia—Tamoxifen—pancreatic cancer	0.000155	0.0065	CcSEcCtD
Diphenhydramine—Anorexia—Erlotinib—pancreatic cancer	0.000153	0.00644	CcSEcCtD
Diphenhydramine—Convulsion—Sunitinib—pancreatic cancer	0.000147	0.0062	CcSEcCtD
Diphenhydramine—Insomnia—Tamoxifen—pancreatic cancer	0.000147	0.00617	CcSEcCtD
Diphenhydramine—Paraesthesia—Tamoxifen—pancreatic cancer	0.000146	0.00613	CcSEcCtD
Diphenhydramine—Insomnia—Erlotinib—pancreatic cancer	0.000145	0.00611	CcSEcCtD
Diphenhydramine—Chills—Irinotecan—pancreatic cancer	0.000145	0.00608	CcSEcCtD
Diphenhydramine—Dyspepsia—Tamoxifen—pancreatic cancer	0.000143	0.00601	CcSEcCtD
Diphenhydramine—Dry mouth—Sunitinib—pancreatic cancer	0.000142	0.00596	CcSEcCtD
Diphenhydramine—Dyspepsia—Erlotinib—pancreatic cancer	0.000141	0.00594	CcSEcCtD
Diphenhydramine—Decreased appetite—Tamoxifen—pancreatic cancer	0.000141	0.00593	CcSEcCtD
Diphenhydramine—Chills—Gemcitabine—pancreatic cancer	0.000141	0.00592	CcSEcCtD
Diphenhydramine—Fatigue—Tamoxifen—pancreatic cancer	0.00014	0.00588	CcSEcCtD
Diphenhydramine—Decreased appetite—Erlotinib—pancreatic cancer	0.00014	0.00587	CcSEcCtD
Diphenhydramine—Constipation—Tamoxifen—pancreatic cancer	0.000139	0.00584	CcSEcCtD
Diphenhydramine—Fatigue—Erlotinib—pancreatic cancer	0.000138	0.00582	CcSEcCtD
Diphenhydramine—Constipation—Erlotinib—pancreatic cancer	0.000137	0.00577	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Sunitinib—pancreatic cancer	0.000136	0.00572	CcSEcCtD
Diphenhydramine—Anorexia—Sunitinib—pancreatic cancer	0.000132	0.00557	CcSEcCtD
Diphenhydramine—Urticaria—Tamoxifen—pancreatic cancer	0.000129	0.00542	CcSEcCtD
Diphenhydramine—Vision blurred—Fluorouracil—pancreatic cancer	0.000127	0.00532	CcSEcCtD
Diphenhydramine—Vertigo—Irinotecan—pancreatic cancer	0.000126	0.0053	CcSEcCtD
Diphenhydramine—Insomnia—Sunitinib—pancreatic cancer	0.000126	0.00529	CcSEcCtD
Diphenhydramine—Paraesthesia—Sunitinib—pancreatic cancer	0.000125	0.00525	CcSEcCtD
Diphenhydramine—Photosensitivity—Epirubicin—pancreatic cancer	0.000124	0.0052	CcSEcCtD
Diphenhydramine—Dyspepsia—Sunitinib—pancreatic cancer	0.000122	0.00514	CcSEcCtD
Diphenhydramine—Neuropathy peripheral—Docetaxel—pancreatic cancer	0.000122	0.00512	CcSEcCtD
Diphenhydramine—Decreased appetite—Sunitinib—pancreatic cancer	0.000121	0.00508	CcSEcCtD
Diphenhydramine—Fatigue—Sunitinib—pancreatic cancer	0.00012	0.00504	CcSEcCtD
Diphenhydramine—Constipation—Sunitinib—pancreatic cancer	0.000119	0.005	CcSEcCtD
Diphenhydramine—Asthenia—Tamoxifen—pancreatic cancer	0.000116	0.0049	CcSEcCtD
Diphenhydramine—Convulsion—Fluorouracil—pancreatic cancer	0.000116	0.0049	CcSEcCtD
Diphenhydramine—Agranulocytosis—Docetaxel—pancreatic cancer	0.000116	0.00487	CcSEcCtD
Diphenhydramine—Confusional state—Irinotecan—pancreatic cancer	0.000115	0.00485	CcSEcCtD
Diphenhydramine—Asthenia—Erlotinib—pancreatic cancer	0.000115	0.00484	CcSEcCtD
Diphenhydramine—Photosensitivity—Doxorubicin—pancreatic cancer	0.000114	0.00481	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Irinotecan—pancreatic cancer	0.000112	0.00471	CcSEcCtD
Diphenhydramine—Diarrhoea—Tamoxifen—pancreatic cancer	0.000111	0.00467	CcSEcCtD
Diphenhydramine—Hyperhidrosis—Irinotecan—pancreatic cancer	0.000111	0.00465	CcSEcCtD
Diphenhydramine—Confusional state—Fluorouracil—pancreatic cancer	0.000111	0.00465	CcSEcCtD
Diphenhydramine—Diarrhoea—Erlotinib—pancreatic cancer	0.00011	0.00462	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.000109	0.00459	CcSEcCtD
Diphenhydramine—Anorexia—Irinotecan—pancreatic cancer	0.000109	0.00459	CcSEcCtD
Diphenhydramine—Diplopia—Epirubicin—pancreatic cancer	0.000109	0.00457	CcSEcCtD
Diphenhydramine—Hyperhidrosis—Gemcitabine—pancreatic cancer	0.000108	0.00453	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.000107	0.00451	CcSEcCtD
Diphenhydramine—Dizziness—Tamoxifen—pancreatic cancer	0.000107	0.00451	CcSEcCtD
Diphenhydramine—Tachycardia—Fluorouracil—pancreatic cancer	0.000107	0.0045	CcSEcCtD
Diphenhydramine—Hypotension—Irinotecan—pancreatic cancer	0.000107	0.0045	CcSEcCtD
Diphenhydramine—Anorexia—Gemcitabine—pancreatic cancer	0.000106	0.00447	CcSEcCtD
Diphenhydramine—Dizziness—Erlotinib—pancreatic cancer	0.000106	0.00446	CcSEcCtD
Diphenhydramine—Anorexia—Fluorouracil—pancreatic cancer	0.000104	0.0044	CcSEcCtD
Diphenhydramine—Hypotension—Gemcitabine—pancreatic cancer	0.000104	0.00438	CcSEcCtD
Diphenhydramine—Insomnia—Irinotecan—pancreatic cancer	0.000104	0.00435	CcSEcCtD
Diphenhydramine—Vomiting—Tamoxifen—pancreatic cancer	0.000103	0.00434	CcSEcCtD
Diphenhydramine—Paraesthesia—Irinotecan—pancreatic cancer	0.000103	0.00432	CcSEcCtD
Diphenhydramine—Hypotension—Fluorouracil—pancreatic cancer	0.000102	0.00431	CcSEcCtD
Diphenhydramine—Rash—Tamoxifen—pancreatic cancer	0.000102	0.0043	CcSEcCtD
Diphenhydramine—Dermatitis—Tamoxifen—pancreatic cancer	0.000102	0.0043	CcSEcCtD
Diphenhydramine—Vomiting—Erlotinib—pancreatic cancer	0.000102	0.00429	CcSEcCtD
Diphenhydramine—Somnolence—Irinotecan—pancreatic cancer	0.000102	0.00428	CcSEcCtD
Diphenhydramine—Headache—Tamoxifen—pancreatic cancer	0.000102	0.00428	CcSEcCtD
Diphenhydramine—Rash—Erlotinib—pancreatic cancer	0.000101	0.00426	CcSEcCtD
Diphenhydramine—Dermatitis—Erlotinib—pancreatic cancer	0.000101	0.00425	CcSEcCtD
Diphenhydramine—Insomnia—Gemcitabine—pancreatic cancer	0.000101	0.00424	CcSEcCtD
Diphenhydramine—Dyspepsia—Irinotecan—pancreatic cancer	0.000101	0.00424	CcSEcCtD
Diphenhydramine—Headache—Erlotinib—pancreatic cancer	0.000101	0.00423	CcSEcCtD
Diphenhydramine—Diplopia—Doxorubicin—pancreatic cancer	0.0001	0.00423	CcSEcCtD
Diphenhydramine—Paraesthesia—Gemcitabine—pancreatic cancer	0.0001	0.00421	CcSEcCtD
Diphenhydramine—Chills—Docetaxel—pancreatic cancer	9.99e-05	0.0042	CcSEcCtD
Diphenhydramine—Asthenia—Sunitinib—pancreatic cancer	9.97e-05	0.00419	CcSEcCtD
Diphenhydramine—Decreased appetite—Irinotecan—pancreatic cancer	9.95e-05	0.00419	CcSEcCtD
Diphenhydramine—Insomnia—Fluorouracil—pancreatic cancer	9.91e-05	0.00417	CcSEcCtD
Diphenhydramine—Somnolence—Gemcitabine—pancreatic cancer	9.91e-05	0.00417	CcSEcCtD
Diphenhydramine—Fatigue—Irinotecan—pancreatic cancer	9.87e-05	0.00415	CcSEcCtD
Diphenhydramine—Paraesthesia—Fluorouracil—pancreatic cancer	9.84e-05	0.00414	CcSEcCtD
Diphenhydramine—Constipation—Irinotecan—pancreatic cancer	9.79e-05	0.00412	CcSEcCtD
Diphenhydramine—Somnolence—Fluorouracil—pancreatic cancer	9.74e-05	0.0041	CcSEcCtD
Diphenhydramine—Decreased appetite—Gemcitabine—pancreatic cancer	9.69e-05	0.00408	CcSEcCtD
Diphenhydramine—Dyspepsia—Fluorouracil—pancreatic cancer	9.65e-05	0.00406	CcSEcCtD
Diphenhydramine—Nausea—Tamoxifen—pancreatic cancer	9.63e-05	0.00405	CcSEcCtD
Diphenhydramine—Fatigue—Gemcitabine—pancreatic cancer	9.61e-05	0.00404	CcSEcCtD
Diphenhydramine—Constipation—Gemcitabine—pancreatic cancer	9.53e-05	0.00401	CcSEcCtD
Diphenhydramine—Nausea—Erlotinib—pancreatic cancer	9.53e-05	0.00401	CcSEcCtD
Diphenhydramine—Decreased appetite—Fluorouracil—pancreatic cancer	9.53e-05	0.00401	CcSEcCtD
Diphenhydramine—Diarrhoea—Sunitinib—pancreatic cancer	9.51e-05	0.004	CcSEcCtD
Diphenhydramine—Feeling abnormal—Irinotecan—pancreatic cancer	9.43e-05	0.00397	CcSEcCtD
Diphenhydramine—Dizziness—Sunitinib—pancreatic cancer	9.19e-05	0.00387	CcSEcCtD
Diphenhydramine—Feeling abnormal—Gemcitabine—pancreatic cancer	9.19e-05	0.00386	CcSEcCtD
Diphenhydramine—Feeling abnormal—Fluorouracil—pancreatic cancer	9.03e-05	0.0038	CcSEcCtD
Diphenhydramine—Vomiting—Sunitinib—pancreatic cancer	8.83e-05	0.00372	CcSEcCtD
Diphenhydramine—Dysuria—Epirubicin—pancreatic cancer	8.77e-05	0.00369	CcSEcCtD
Diphenhydramine—Rash—Sunitinib—pancreatic cancer	8.76e-05	0.00369	CcSEcCtD
Diphenhydramine—Dermatitis—Sunitinib—pancreatic cancer	8.75e-05	0.00368	CcSEcCtD
Diphenhydramine—Urticaria—Fluorouracil—pancreatic cancer	8.71e-05	0.00366	CcSEcCtD
Diphenhydramine—Headache—Sunitinib—pancreatic cancer	8.7e-05	0.00366	CcSEcCtD
Diphenhydramine—Pollakiuria—Epirubicin—pancreatic cancer	8.67e-05	0.00365	CcSEcCtD
Diphenhydramine—Palpitations—Docetaxel—pancreatic cancer	8.57e-05	0.0036	CcSEcCtD
Diphenhydramine—Photosensitivity reaction—Epirubicin—pancreatic cancer	8.56e-05	0.0036	CcSEcCtD
Diphenhydramine—Convulsion—Docetaxel—pancreatic cancer	8.4e-05	0.00353	CcSEcCtD
Diphenhydramine—Drowsiness—Epirubicin—pancreatic cancer	8.37e-05	0.00352	CcSEcCtD
Diphenhydramine—Nausea—Sunitinib—pancreatic cancer	8.25e-05	0.00347	CcSEcCtD
Diphenhydramine—Asthenia—Irinotecan—pancreatic cancer	8.21e-05	0.00345	CcSEcCtD
Diphenhydramine—Neuropathy peripheral—Epirubicin—pancreatic cancer	8.2e-05	0.00345	CcSEcCtD
Diphenhydramine—Dysuria—Doxorubicin—pancreatic cancer	8.12e-05	0.00342	CcSEcCtD
Diphenhydramine—Dry mouth—Docetaxel—pancreatic cancer	8.07e-05	0.0034	CcSEcCtD
Diphenhydramine—Pollakiuria—Doxorubicin—pancreatic cancer	8.02e-05	0.00337	CcSEcCtD
Diphenhydramine—Asthenia—Gemcitabine—pancreatic cancer	8e-05	0.00336	CcSEcCtD
Diphenhydramine—Confusional state—Docetaxel—pancreatic cancer	7.98e-05	0.00336	CcSEcCtD
Diphenhydramine—Photosensitivity reaction—Doxorubicin—pancreatic cancer	7.92e-05	0.00333	CcSEcCtD
Diphenhydramine—Diarrhoea—Irinotecan—pancreatic cancer	7.83e-05	0.00329	CcSEcCtD
Diphenhydramine—Agranulocytosis—Epirubicin—pancreatic cancer	7.81e-05	0.00328	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Docetaxel—pancreatic cancer	7.75e-05	0.00326	CcSEcCtD
Diphenhydramine—Drowsiness—Doxorubicin—pancreatic cancer	7.74e-05	0.00326	CcSEcCtD
Diphenhydramine—Tachycardia—Docetaxel—pancreatic cancer	7.72e-05	0.00325	CcSEcCtD
Diphenhydramine—Diarrhoea—Gemcitabine—pancreatic cancer	7.63e-05	0.00321	CcSEcCtD
Diphenhydramine—Neuropathy peripheral—Doxorubicin—pancreatic cancer	7.59e-05	0.00319	CcSEcCtD
Diphenhydramine—Dizziness—Irinotecan—pancreatic cancer	7.57e-05	0.00318	CcSEcCtD
Diphenhydramine—Anorexia—Docetaxel—pancreatic cancer	7.54e-05	0.00317	CcSEcCtD
Diphenhydramine—Diarrhoea—Fluorouracil—pancreatic cancer	7.5e-05	0.00315	CcSEcCtD
Diphenhydramine—Hypotension—Docetaxel—pancreatic cancer	7.39e-05	0.00311	CcSEcCtD
Diphenhydramine—Vomiting—Irinotecan—pancreatic cancer	7.28e-05	0.00306	CcSEcCtD
Diphenhydramine—Dizziness—Fluorouracil—pancreatic cancer	7.25e-05	0.00305	CcSEcCtD
Diphenhydramine—Agranulocytosis—Doxorubicin—pancreatic cancer	7.22e-05	0.00304	CcSEcCtD
Diphenhydramine—Rash—Irinotecan—pancreatic cancer	7.22e-05	0.00304	CcSEcCtD
Diphenhydramine—Dermatitis—Irinotecan—pancreatic cancer	7.21e-05	0.00303	CcSEcCtD
Diphenhydramine—Headache—Irinotecan—pancreatic cancer	7.17e-05	0.00302	CcSEcCtD
Diphenhydramine—Insomnia—Docetaxel—pancreatic cancer	7.16e-05	0.00301	CcSEcCtD
Diphenhydramine—Paraesthesia—Docetaxel—pancreatic cancer	7.1e-05	0.00299	CcSEcCtD
Diphenhydramine—Vomiting—Gemcitabine—pancreatic cancer	7.09e-05	0.00298	CcSEcCtD
Diphenhydramine—Somnolence—Docetaxel—pancreatic cancer	7.03e-05	0.00296	CcSEcCtD
Diphenhydramine—Rash—Gemcitabine—pancreatic cancer	7.03e-05	0.00296	CcSEcCtD
Diphenhydramine—Dermatitis—Gemcitabine—pancreatic cancer	7.02e-05	0.00295	CcSEcCtD
Diphenhydramine—Tinnitus—Epirubicin—pancreatic cancer	7e-05	0.00295	CcSEcCtD
Diphenhydramine—Headache—Gemcitabine—pancreatic cancer	6.98e-05	0.00294	CcSEcCtD
Diphenhydramine—Vomiting—Fluorouracil—pancreatic cancer	6.97e-05	0.00293	CcSEcCtD
Diphenhydramine—Dyspepsia—Docetaxel—pancreatic cancer	6.96e-05	0.00293	CcSEcCtD
Diphenhydramine—Rash—Fluorouracil—pancreatic cancer	6.91e-05	0.00291	CcSEcCtD
Diphenhydramine—Dermatitis—Fluorouracil—pancreatic cancer	6.9e-05	0.0029	CcSEcCtD
Diphenhydramine—Decreased appetite—Docetaxel—pancreatic cancer	6.88e-05	0.00289	CcSEcCtD
Diphenhydramine—Headache—Fluorouracil—pancreatic cancer	6.87e-05	0.00289	CcSEcCtD
Diphenhydramine—Fatigue—Docetaxel—pancreatic cancer	6.82e-05	0.00287	CcSEcCtD
Diphenhydramine—Nausea—Irinotecan—pancreatic cancer	6.8e-05	0.00286	CcSEcCtD
Diphenhydramine—Constipation—Docetaxel—pancreatic cancer	6.76e-05	0.00285	CcSEcCtD
Diphenhydramine—Chills—Epirubicin—pancreatic cancer	6.74e-05	0.00284	CcSEcCtD
Diphenhydramine—Nausea—Gemcitabine—pancreatic cancer	6.62e-05	0.00279	CcSEcCtD
Diphenhydramine—Feeling abnormal—Docetaxel—pancreatic cancer	6.52e-05	0.00274	CcSEcCtD
Diphenhydramine—Nausea—Fluorouracil—pancreatic cancer	6.51e-05	0.00274	CcSEcCtD
Diphenhydramine—Tinnitus—Doxorubicin—pancreatic cancer	6.48e-05	0.00273	CcSEcCtD
Diphenhydramine—Tension—Epirubicin—pancreatic cancer	6.42e-05	0.0027	CcSEcCtD
Diphenhydramine—Nervousness—Epirubicin—pancreatic cancer	6.35e-05	0.00267	CcSEcCtD
Diphenhydramine—Chills—Doxorubicin—pancreatic cancer	6.24e-05	0.00262	CcSEcCtD
Diphenhydramine—Vision blurred—Epirubicin—pancreatic cancer	6.16e-05	0.00259	CcSEcCtD
Diphenhydramine—Agitation—Epirubicin—pancreatic cancer	6.01e-05	0.00253	CcSEcCtD
Diphenhydramine—Tension—Doxorubicin—pancreatic cancer	5.94e-05	0.0025	CcSEcCtD
Diphenhydramine—Nervousness—Doxorubicin—pancreatic cancer	5.88e-05	0.00247	CcSEcCtD
Diphenhydramine—Vertigo—Epirubicin—pancreatic cancer	5.87e-05	0.00247	CcSEcCtD
Diphenhydramine—Palpitations—Epirubicin—pancreatic cancer	5.78e-05	0.00243	CcSEcCtD
Diphenhydramine—Vision blurred—Doxorubicin—pancreatic cancer	5.7e-05	0.0024	CcSEcCtD
Diphenhydramine—Asthenia—Docetaxel—pancreatic cancer	5.68e-05	0.00239	CcSEcCtD
Diphenhydramine—Convulsion—Epirubicin—pancreatic cancer	5.66e-05	0.00238	CcSEcCtD
Diphenhydramine—Agitation—Doxorubicin—pancreatic cancer	5.56e-05	0.00234	CcSEcCtD
Diphenhydramine—Dry mouth—Epirubicin—pancreatic cancer	5.44e-05	0.00229	CcSEcCtD
Diphenhydramine—Vertigo—Doxorubicin—pancreatic cancer	5.44e-05	0.00229	CcSEcCtD
Diphenhydramine—Diarrhoea—Docetaxel—pancreatic cancer	5.41e-05	0.00228	CcSEcCtD
Diphenhydramine—Confusional state—Epirubicin—pancreatic cancer	5.38e-05	0.00226	CcSEcCtD
Diphenhydramine—Palpitations—Doxorubicin—pancreatic cancer	5.35e-05	0.00225	CcSEcCtD
Diphenhydramine—Convulsion—Doxorubicin—pancreatic cancer	5.24e-05	0.00221	CcSEcCtD
Diphenhydramine—Dizziness—Docetaxel—pancreatic cancer	5.23e-05	0.0022	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Epirubicin—pancreatic cancer	5.22e-05	0.0022	CcSEcCtD
Diphenhydramine—Tachycardia—Epirubicin—pancreatic cancer	5.21e-05	0.00219	CcSEcCtD
Diphenhydramine—Hyperhidrosis—Epirubicin—pancreatic cancer	5.16e-05	0.00217	CcSEcCtD
Diphenhydramine—Anorexia—Epirubicin—pancreatic cancer	5.09e-05	0.00214	CcSEcCtD
Diphenhydramine—Dry mouth—Doxorubicin—pancreatic cancer	5.04e-05	0.00212	CcSEcCtD
Diphenhydramine—Vomiting—Docetaxel—pancreatic cancer	5.03e-05	0.00212	CcSEcCtD
Diphenhydramine—Rash—Docetaxel—pancreatic cancer	4.99e-05	0.0021	CcSEcCtD
Diphenhydramine—Hypotension—Epirubicin—pancreatic cancer	4.99e-05	0.0021	CcSEcCtD
Diphenhydramine—Dermatitis—Docetaxel—pancreatic cancer	4.98e-05	0.0021	CcSEcCtD
Diphenhydramine—Confusional state—Doxorubicin—pancreatic cancer	4.98e-05	0.00209	CcSEcCtD
Diphenhydramine—Headache—Docetaxel—pancreatic cancer	4.96e-05	0.00208	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Doxorubicin—pancreatic cancer	4.83e-05	0.00203	CcSEcCtD
Diphenhydramine—Insomnia—Epirubicin—pancreatic cancer	4.83e-05	0.00203	CcSEcCtD
Diphenhydramine—Tachycardia—Doxorubicin—pancreatic cancer	4.82e-05	0.00203	CcSEcCtD
Diphenhydramine—Paraesthesia—Epirubicin—pancreatic cancer	4.79e-05	0.00202	CcSEcCtD
Diphenhydramine—Hyperhidrosis—Doxorubicin—pancreatic cancer	4.77e-05	0.00201	CcSEcCtD
Diphenhydramine—Somnolence—Epirubicin—pancreatic cancer	4.74e-05	0.002	CcSEcCtD
Diphenhydramine—Anorexia—Doxorubicin—pancreatic cancer	4.71e-05	0.00198	CcSEcCtD
Diphenhydramine—Nausea—Docetaxel—pancreatic cancer	4.7e-05	0.00198	CcSEcCtD
Diphenhydramine—Dyspepsia—Epirubicin—pancreatic cancer	4.7e-05	0.00198	CcSEcCtD
Diphenhydramine—Decreased appetite—Epirubicin—pancreatic cancer	4.64e-05	0.00195	CcSEcCtD
Diphenhydramine—Hypotension—Doxorubicin—pancreatic cancer	4.61e-05	0.00194	CcSEcCtD
Diphenhydramine—Fatigue—Epirubicin—pancreatic cancer	4.6e-05	0.00194	CcSEcCtD
Diphenhydramine—Constipation—Epirubicin—pancreatic cancer	4.56e-05	0.00192	CcSEcCtD
Diphenhydramine—Insomnia—Doxorubicin—pancreatic cancer	4.47e-05	0.00188	CcSEcCtD
Diphenhydramine—Paraesthesia—Doxorubicin—pancreatic cancer	4.43e-05	0.00187	CcSEcCtD
Diphenhydramine—Feeling abnormal—Epirubicin—pancreatic cancer	4.4e-05	0.00185	CcSEcCtD
Diphenhydramine—Somnolence—Doxorubicin—pancreatic cancer	4.39e-05	0.00185	CcSEcCtD
Diphenhydramine—Dyspepsia—Doxorubicin—pancreatic cancer	4.35e-05	0.00183	CcSEcCtD
Diphenhydramine—Decreased appetite—Doxorubicin—pancreatic cancer	4.29e-05	0.00181	CcSEcCtD
Diphenhydramine—Fatigue—Doxorubicin—pancreatic cancer	4.26e-05	0.00179	CcSEcCtD
Diphenhydramine—Urticaria—Epirubicin—pancreatic cancer	4.24e-05	0.00178	CcSEcCtD
Diphenhydramine—Constipation—Doxorubicin—pancreatic cancer	4.22e-05	0.00178	CcSEcCtD
Diphenhydramine—Feeling abnormal—Doxorubicin—pancreatic cancer	4.07e-05	0.00171	CcSEcCtD
Diphenhydramine—Urticaria—Doxorubicin—pancreatic cancer	3.92e-05	0.00165	CcSEcCtD
Diphenhydramine—Asthenia—Epirubicin—pancreatic cancer	3.83e-05	0.00161	CcSEcCtD
Diphenhydramine—Diarrhoea—Epirubicin—pancreatic cancer	3.65e-05	0.00154	CcSEcCtD
Diphenhydramine—Asthenia—Doxorubicin—pancreatic cancer	3.54e-05	0.00149	CcSEcCtD
Diphenhydramine—Dizziness—Epirubicin—pancreatic cancer	3.53e-05	0.00148	CcSEcCtD
Diphenhydramine—Vomiting—Epirubicin—pancreatic cancer	3.39e-05	0.00143	CcSEcCtD
Diphenhydramine—Diarrhoea—Doxorubicin—pancreatic cancer	3.38e-05	0.00142	CcSEcCtD
Diphenhydramine—Rash—Epirubicin—pancreatic cancer	3.36e-05	0.00142	CcSEcCtD
Diphenhydramine—Dermatitis—Epirubicin—pancreatic cancer	3.36e-05	0.00141	CcSEcCtD
Diphenhydramine—Headache—Epirubicin—pancreatic cancer	3.34e-05	0.00141	CcSEcCtD
Diphenhydramine—Dizziness—Doxorubicin—pancreatic cancer	3.26e-05	0.00137	CcSEcCtD
Diphenhydramine—Nausea—Epirubicin—pancreatic cancer	3.17e-05	0.00133	CcSEcCtD
Diphenhydramine—Vomiting—Doxorubicin—pancreatic cancer	3.14e-05	0.00132	CcSEcCtD
Diphenhydramine—Rash—Doxorubicin—pancreatic cancer	3.11e-05	0.00131	CcSEcCtD
Diphenhydramine—Dermatitis—Doxorubicin—pancreatic cancer	3.11e-05	0.00131	CcSEcCtD
Diphenhydramine—Headache—Doxorubicin—pancreatic cancer	3.09e-05	0.0013	CcSEcCtD
Diphenhydramine—Nausea—Doxorubicin—pancreatic cancer	2.93e-05	0.00123	CcSEcCtD
Diphenhydramine—CHRM2—Signaling Pathways—PTCH1—pancreatic cancer	8.67e-07	0.000516	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—PPARG—pancreatic cancer	8.56e-07	0.000509	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	8.49e-07	0.000506	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	8.19e-07	0.000488	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—SST—pancreatic cancer	8.06e-07	0.00048	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—TYMS—pancreatic cancer	8.02e-07	0.000477	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—GLP1R—pancreatic cancer	8e-07	0.000477	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—PIK3CG—pancreatic cancer	7.95e-07	0.000473	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—SST—pancreatic cancer	7.93e-07	0.000472	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—JAG1—pancreatic cancer	7.89e-07	0.00047	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—DPYD—pancreatic cancer	7.87e-07	0.000469	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—NOTCH3—pancreatic cancer	7.85e-07	0.000468	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—PIK3CG—pancreatic cancer	7.82e-07	0.000466	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—PIK3CD—pancreatic cancer	7.79e-07	0.000464	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—TYMS—pancreatic cancer	7.78e-07	0.000463	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—JAG1—pancreatic cancer	7.76e-07	0.000462	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—TYMP—pancreatic cancer	7.74e-07	0.000461	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—NOTCH3—pancreatic cancer	7.73e-07	0.00046	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—CD44—pancreatic cancer	7.66e-07	0.000456	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—SLC2A2—pancreatic cancer	7.47e-07	0.000445	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—TYMS—pancreatic cancer	7.47e-07	0.000445	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	7.47e-07	0.000445	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CNR1—pancreatic cancer	7.44e-07	0.000443	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	7.39e-07	0.00044	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—GLP1R—pancreatic cancer	7.36e-07	0.000438	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—GCG—pancreatic cancer	7.34e-07	0.000437	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CNR1—pancreatic cancer	7.32e-07	0.000436	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—GLP1R—pancreatic cancer	7.3e-07	0.000435	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—DPYD—pancreatic cancer	7.24e-07	0.000431	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—PIK3CG—pancreatic cancer	7.22e-07	0.00043	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—GCG—pancreatic cancer	7.18e-07	0.000428	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—DPYD—pancreatic cancer	7.18e-07	0.000428	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	7.14e-07	0.000425	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—PIK3CG—pancreatic cancer	7.1e-07	0.000423	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—GCG—pancreatic cancer	7.07e-07	0.000421	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—PIK3CD—pancreatic cancer	6.99e-07	0.000416	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—STK11—pancreatic cancer	6.9e-07	0.000411	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—PIK3CD—pancreatic cancer	6.87e-07	0.000409	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—SLC2A2—pancreatic cancer	6.87e-07	0.000409	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—AGTR1—pancreatic cancer	6.85e-07	0.000408	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—SLC2A2—pancreatic cancer	6.81e-07	0.000406	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—PIK3CB—pancreatic cancer	6.79e-07	0.000404	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—STK11—pancreatic cancer	6.75e-07	0.000402	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	6.74e-07	0.000401	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—AGTR1—pancreatic cancer	6.74e-07	0.000401	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—PTGS2—pancreatic cancer	6.73e-07	0.000401	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—STK11—pancreatic cancer	6.64e-07	0.000396	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—APOE—pancreatic cancer	6.52e-07	0.000388	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	6.51e-07	0.000387	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	6.5e-07	0.000387	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	6.38e-07	0.00038	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—PIK3CD—pancreatic cancer	6.34e-07	0.000378	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—APOE—pancreatic cancer	6.33e-07	0.000377	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—PIK3CD—pancreatic cancer	6.24e-07	0.000372	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—GLP1R—pancreatic cancer	6.24e-07	0.000371	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—DPYD—pancreatic cancer	6.14e-07	0.000365	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—PIK3CB—pancreatic cancer	6.09e-07	0.000363	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—APOE—pancreatic cancer	6.08e-07	0.000362	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—PIK3CB—pancreatic cancer	5.99e-07	0.000357	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	5.99e-07	0.000357	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—TYMS—pancreatic cancer	5.94e-07	0.000354	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	5.93e-07	0.000353	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—SMAD4—pancreatic cancer	5.91e-07	0.000352	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—PIK3CG—pancreatic cancer	5.88e-07	0.00035	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—PTEN—pancreatic cancer	5.87e-07	0.000349	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—CXCL8—pancreatic cancer	5.85e-07	0.000348	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—SLC2A2—pancreatic cancer	5.82e-07	0.000347	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—SMAD4—pancreatic cancer	5.82e-07	0.000346	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—CD44—pancreatic cancer	5.79e-07	0.000345	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—HES1—pancreatic cancer	5.77e-07	0.000344	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	5.76e-07	0.000343	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—CXCL8—pancreatic cancer	5.76e-07	0.000343	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—PIK3CG—pancreatic cancer	5.71e-07	0.00034	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—HES1—pancreatic cancer	5.68e-07	0.000338	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—PPARG—pancreatic cancer	5.68e-07	0.000338	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	5.67e-07	0.000337	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	5.61e-07	0.000334	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	5.56e-07	0.000331	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—GCG—pancreatic cancer	5.55e-07	0.00033	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—PIK3CB—pancreatic cancer	5.53e-07	0.000329	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—PPARG—pancreatic cancer	5.51e-07	0.000328	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—PIK3CG—pancreatic cancer	5.48e-07	0.000327	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—PIK3CB—pancreatic cancer	5.44e-07	0.000324	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—CD44—pancreatic cancer	5.32e-07	0.000317	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—CXCL8—pancreatic cancer	5.31e-07	0.000316	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—PPARG—pancreatic cancer	5.29e-07	0.000315	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—CD44—pancreatic cancer	5.28e-07	0.000314	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—CXCL8—pancreatic cancer	5.23e-07	0.000311	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—STK11—pancreatic cancer	5.22e-07	0.000311	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—PIK3CD—pancreatic cancer	5.17e-07	0.000308	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	5.17e-07	0.000308	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	5.12e-07	0.000305	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—GCG—pancreatic cancer	5.1e-07	0.000304	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	5.07e-07	0.000302	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—TERT—pancreatic cancer	5.06e-07	0.000301	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—GCG—pancreatic cancer	5.06e-07	0.000301	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—PIK3CD—pancreatic cancer	5.02e-07	0.000299	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—TERT—pancreatic cancer	4.98e-07	0.000296	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	4.9e-07	0.000292	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—HIF1A—pancreatic cancer	4.84e-07	0.000288	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—APOE—pancreatic cancer	4.83e-07	0.000288	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—TSC2—pancreatic cancer	4.83e-07	0.000287	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—PIK3CD—pancreatic cancer	4.82e-07	0.000287	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—STK11—pancreatic cancer	4.8e-07	0.000286	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—HIF1A—pancreatic cancer	4.76e-07	0.000284	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—STK11—pancreatic cancer	4.76e-07	0.000283	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—TSC2—pancreatic cancer	4.75e-07	0.000283	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—APOE—pancreatic cancer	4.72e-07	0.000281	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—APOE—pancreatic cancer	4.65e-07	0.000277	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—KDR—pancreatic cancer	4.63e-07	0.000276	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—KDR—pancreatic cancer	4.55e-07	0.000271	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—CD44—pancreatic cancer	4.51e-07	0.000268	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—PIK3CB—pancreatic cancer	4.51e-07	0.000268	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—TYMS—pancreatic cancer	4.49e-07	0.000267	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—PTGS2—pancreatic cancer	4.47e-07	0.000266	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	4.46e-07	0.000266	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	4.42e-07	0.000263	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—NFKBIA—pancreatic cancer	4.4e-07	0.000262	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—PIK3CB—pancreatic cancer	4.38e-07	0.000261	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	4.37e-07	0.00026	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—NOTCH1—pancreatic cancer	4.36e-07	0.00026	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—PIK3CG—pancreatic cancer	4.36e-07	0.000259	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—PTGS2—pancreatic cancer	4.34e-07	0.000258	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—NFKBIA—pancreatic cancer	4.33e-07	0.000258	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—GCG—pancreatic cancer	4.32e-07	0.000257	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—NOTCH1—pancreatic cancer	4.29e-07	0.000255	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—PIK3CG—pancreatic cancer	4.26e-07	0.000254	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—NRAS—pancreatic cancer	4.26e-07	0.000254	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—EGF—pancreatic cancer	4.21e-07	0.000251	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—PPARG—pancreatic cancer	4.21e-07	0.00025	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—PIK3CB—pancreatic cancer	4.2e-07	0.00025	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—PIK3CG—pancreatic cancer	4.19e-07	0.00025	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—NRAS—pancreatic cancer	4.19e-07	0.00025	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—PTGS2—pancreatic cancer	4.16e-07	0.000248	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—EGF—pancreatic cancer	4.15e-07	0.000247	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—PIK3CA—pancreatic cancer	4.14e-07	0.000247	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—TYMS—pancreatic cancer	4.13e-07	0.000246	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—TYMS—pancreatic cancer	4.09e-07	0.000244	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—STK11—pancreatic cancer	4.06e-07	0.000242	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—PTEN—pancreatic cancer	3.9e-07	0.000232	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—EGFR—pancreatic cancer	3.88e-07	0.000231	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—PIK3CD—pancreatic cancer	3.83e-07	0.000228	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—EGFR—pancreatic cancer	3.82e-07	0.000228	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	3.82e-07	0.000227	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—PTEN—pancreatic cancer	3.78e-07	0.000225	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—PIK3CD—pancreatic cancer	3.75e-07	0.000223	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—PIK3CA—pancreatic cancer	3.71e-07	0.000221	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—PIK3CD—pancreatic cancer	3.69e-07	0.00022	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—KRAS—pancreatic cancer	3.67e-07	0.000218	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—PIK3CA—pancreatic cancer	3.65e-07	0.000217	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—APOE—pancreatic cancer	3.65e-07	0.000217	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—PTEN—pancreatic cancer	3.63e-07	0.000216	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—KRAS—pancreatic cancer	3.61e-07	0.000215	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—TYMS—pancreatic cancer	3.5e-07	0.000208	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	3.45e-07	0.000206	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—AKT1—pancreatic cancer	3.38e-07	0.000201	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—PIK3CA—pancreatic cancer	3.37e-07	0.000201	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—APOE—pancreatic cancer	3.36e-07	0.0002	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—PIK3CB—pancreatic cancer	3.34e-07	0.000199	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—APOE—pancreatic cancer	3.33e-07	0.000198	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—PIK3CA—pancreatic cancer	3.32e-07	0.000198	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—PTGS2—pancreatic cancer	3.31e-07	0.000197	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—PIK3CG—pancreatic cancer	3.29e-07	0.000196	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—PIK3CB—pancreatic cancer	3.27e-07	0.000195	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—PIK3CB—pancreatic cancer	3.21e-07	0.000191	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—PPARG—pancreatic cancer	3.18e-07	0.000189	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	3.15e-07	0.000188	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CXCL8—pancreatic cancer	3.14e-07	0.000187	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—HRAS—pancreatic cancer	3.12e-07	0.000186	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CXCL8—pancreatic cancer	3.09e-07	0.000184	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—HRAS—pancreatic cancer	3.07e-07	0.000183	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—AKT1—pancreatic cancer	3.03e-07	0.000181	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—PIK3CG—pancreatic cancer	3.03e-07	0.00018	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CASP3—pancreatic cancer	3e-07	0.000179	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—PIK3CG—pancreatic cancer	3e-07	0.000179	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—AKT1—pancreatic cancer	2.98e-07	0.000178	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CASP3—pancreatic cancer	2.96e-07	0.000176	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CCND1—pancreatic cancer	2.92e-07	0.000174	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—PPARG—pancreatic cancer	2.92e-07	0.000174	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—PPARG—pancreatic cancer	2.9e-07	0.000173	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CTNNB1—pancreatic cancer	2.9e-07	0.000172	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—PIK3CD—pancreatic cancer	2.9e-07	0.000172	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—PTEN—pancreatic cancer	2.89e-07	0.000172	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CCND1—pancreatic cancer	2.88e-07	0.000171	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CTNNB1—pancreatic cancer	2.85e-07	0.00017	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—APOE—pancreatic cancer	2.84e-07	0.000169	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—MMP9—pancreatic cancer	2.84e-07	0.000169	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—PTEN—pancreatic cancer	2.82e-07	0.000168	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—MMP9—pancreatic cancer	2.79e-07	0.000166	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—PTEN—pancreatic cancer	2.78e-07	0.000165	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—AKT1—pancreatic cancer	2.75e-07	0.000164	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—PIK3CA—pancreatic cancer	2.75e-07	0.000164	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—AKT1—pancreatic cancer	2.71e-07	0.000161	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	2.69e-07	0.00016	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—PIK3CA—pancreatic cancer	2.67e-07	0.000159	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	2.66e-07	0.000159	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—PIK3CD—pancreatic cancer	2.64e-07	0.000157	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—SRC—pancreatic cancer	2.62e-07	0.000156	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—SRC—pancreatic cancer	2.58e-07	0.000153	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PIK3CG—pancreatic cancer	2.57e-07	0.000153	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—PIK3CA—pancreatic cancer	2.56e-07	0.000153	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—VEGFA—pancreatic cancer	2.55e-07	0.000152	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—STAT3—pancreatic cancer	2.52e-07	0.00015	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—PIK3CB—pancreatic cancer	2.52e-07	0.00015	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—NRAS—pancreatic cancer	2.52e-07	0.00015	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—VEGFA—pancreatic cancer	2.51e-07	0.000149	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—PTGS2—pancreatic cancer	2.5e-07	0.000149	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—STAT3—pancreatic cancer	2.48e-07	0.000148	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—NRAS—pancreatic cancer	2.48e-07	0.000148	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PPARG—pancreatic cancer	2.48e-07	0.000147	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—MYC—pancreatic cancer	2.35e-07	0.00014	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—TGFB1—pancreatic cancer	2.34e-07	0.000139	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	2.32e-07	0.000138	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—MYC—pancreatic cancer	2.31e-07	0.000137	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—TGFB1—pancreatic cancer	2.3e-07	0.000137	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—PIK3CB—pancreatic cancer	2.3e-07	0.000137	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—PTGS2—pancreatic cancer	2.3e-07	0.000137	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—EGFR—pancreatic cancer	2.29e-07	0.000137	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—PTGS2—pancreatic cancer	2.28e-07	0.000136	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—EGFR—pancreatic cancer	2.26e-07	0.000134	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PIK3CD—pancreatic cancer	2.26e-07	0.000134	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—AKT1—pancreatic cancer	2.25e-07	0.000134	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—PTEN—pancreatic cancer	2.18e-07	0.00013	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—AKT1—pancreatic cancer	2.18e-07	0.00013	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—KRAS—pancreatic cancer	2.17e-07	0.000129	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—KRAS—pancreatic cancer	2.13e-07	0.000127	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—AKT1—pancreatic cancer	2.09e-07	0.000125	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—PIK3CA—pancreatic cancer	2.04e-07	0.000121	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—PTEN—pancreatic cancer	2.01e-07	0.000119	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—PIK3CA—pancreatic cancer	1.99e-07	0.000119	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—PTEN—pancreatic cancer	1.99e-07	0.000118	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PIK3CB—pancreatic cancer	1.97e-07	0.000117	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—PIK3CA—pancreatic cancer	1.96e-07	0.000117	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PTGS2—pancreatic cancer	1.95e-07	0.000116	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—TP53—pancreatic cancer	1.93e-07	0.000115	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—TP53—pancreatic cancer	1.9e-07	0.000113	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—HRAS—pancreatic cancer	1.84e-07	0.00011	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—HRAS—pancreatic cancer	1.81e-07	0.000108	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PTEN—pancreatic cancer	1.7e-07	0.000101	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—AKT1—pancreatic cancer	1.66e-07	9.9e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—AKT1—pancreatic cancer	1.63e-07	9.69e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—AKT1—pancreatic cancer	1.6e-07	9.53e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—PIK3CA—pancreatic cancer	1.54e-07	9.16e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	1.41e-07	8.42e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—PIK3CA—pancreatic cancer	1.4e-07	8.35e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—AKT1—pancreatic cancer	1.26e-07	7.48e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PIK3CA—pancreatic cancer	1.2e-07	7.14e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—AKT1—pancreatic cancer	1.16e-07	6.88e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—AKT1—pancreatic cancer	1.15e-07	6.82e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—AKT1—pancreatic cancer	9.79e-08	5.83e-05	CbGpPWpGaD
